Literature DB >> 11348928

Deleterious effects of inhaled beta-agonists: short-acting and long-acting agents differ.

M R Sears.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11348928     DOI： 10.1378/chest.119.5.1297

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

1.  Inappropriate asthma therapy-a tale of two countries: a parallel population-based cohort study.

Authors:  Manon Belhassen; Anjan Nibber; Eric Van Ganse; Dermot Ryan; Carole Langlois; Francis Appiagyei; Derek Skinner; Laurent Laforest; Joan B Soriano; David Price
Journal:  NPJ Prim Care Respir Med       Date:  2016-10-13       Impact factor: 2.871

2.  Understanding reliever overuse in patients purchasing over-the-counter short-acting beta2 agonists: an Australian community pharmacy-based survey.

Authors:  Elizabeth A Azzi; Vicky Kritikos; Matthew J Peters; David B Price; Pamela Srour; Biljana Cvetkovski; Sinthia Bosnic-Anticevich
Journal:  BMJ Open       Date:  2019-08-14       Impact factor: 2.692

3.  High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma.

Authors:  Anna Jetske Baron; Bertine M J Flokstra-de Blok; Huib A M Kerstjens; Gineke Koopmans-Klein; David B Price; Andrea A Sellink; Ioanna Tsiligianni; Janwillem W H Kocks
Journal:  J Asthma Allergy       Date:  2021-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.